(3R)-3-amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
第一作者:
Aiko,Nitta
第一单位:
Pharmaceutical Research Laboratories, Toray Industries Inc., 6-10-1, Tebiro, Kamakura, Kanagawa 248-8555, Japan. Aiko_Nitta@nts.toray.co.jp
作者:
医学主题词
投药, 口服(Administration, Oral);苯并噻唑类(Benzothiazoles);血糖(Blood Glucose);化学, 药物(Chemistry, Pharmaceutical);二肽基肽酶4(Dipeptidyl Peptidase 4);二肽基肽酶Ⅳ抑制剂(Dipeptidyl-Peptidase IV Inhibitors);药物设计(Drug Design);酶抑制剂(Enzyme Inhibitors);胃排空(Gastric Emptying);胰高血糖素样肽1(Glucagon-Like Peptide 1);葡糖耐量试验(Glucose Tolerance Test);人类(Humans);半数抑制浓度(Inhibitory Concentration 50);胰岛素分泌细胞(Insulin-Secreting Cells);模型, 化学(Models, Chemical);吡喃类(Pyrans)
DOI
10.1016/j.bmcl.2008.09.042
PMID
18819797
发布时间
2010-11-18
- 浏览10
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



